Seamlessly integrating the workflow for the diagnosis and treatment of breast cancer.
In recent decades, research and innovations have made the diagnosis and treatment of cancer more effective and personal. Sources like genomic testing, digital health solutions, advanced imaging, and applying analytics provide access to deep and broad patient-level data. They help us to focus on patients’ individual profiles and tailor care to their needs.
Would you like to know more about our integrated solutions, or do you have other questions? Leave your details and we will get in touch with you.
Matthias Bodmer
Disease Area Manager Oncology
As patients become more knowledgeable, informed and tech savvy, the expectation for innovative and effective treatments increases. However, there is still a need to improve the quality of care in general. It is our ambition to meet and exceed both these demands. Read this article to learn how we do so.
“If the diagnostic test is inaccurate, then the treatment decision based on that test may not be optimal.” The American Food & Drug Administration (FDA) has been issuing guidances on companion diagnostics since 2014. Read their statement here to learn more about their approach.
Provide diagnostic tests to help identify patients most likely to respond to a specific treatment (Companion diagnostics).
Improve patients’ chances of earlier and more specific treatments through more precise diagnostic and prognostic assessments.
Contribute to the development of safer treatments and help to avoid potential adverse events by identifying non-responders to a specific treatment.
